Alkem Laboratories Reports Q1 Unaudited Results for FY26; Profit Stands at 5,209.8 Million
Alkem Laboratories Limited announced the approval of its Standalone and Consolidated Unaudited Financial Results for the quarter ending June 30, 2026. The results were approved by the Board of Directors during a meeting held on August 14, 2026. These quarterly figures reflect the company's performance across both consolidated entities and standalone operations.The company’s Consolidated Financial Results for the quarter ending June 30, 2026, showed Total Income at 38,929.0 million. The results reported a profit for the period of 5,209.8 million and a total comprehensive income of 5,238.6 million.The key financial highlights for consolidated...